[1]万 俊,王 倩,赵倩茹,等.肺腺癌组织中FAM83A的表达[J].郑州大学学报(医学版),2018,(06):785-787.[doi:10.13705/j.issn.1671-6825.2018.04.083]
 WAN Jun,WANG Qian,ZHAO Qianru,et al.Expression of FAM83A in lung adenocarcinoma tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(06):785-787.[doi:10.13705/j.issn.1671-6825.2018.04.083]
点击复制

肺腺癌组织中FAM83A的表达()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2018年06期
页码:
785-787
栏目:
应用研究
出版日期:
2018-11-20

文章信息/Info

Title:
Expression of FAM83A in lung adenocarcinoma tissue
作者:
万 俊王 倩赵倩茹田 蕊
郑州大学第一附属医院老年综合二科 郑州 450052
Author(s):
WAN JunWANG QianZHAO QianruTIAN Rui
Department Ⅱof Geriatrics, the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052
关键词:
肺腺癌 FAM83A 预后
Keywords:
lung adenocarcinoma FAM83A prognosis
分类号:
R734.2
DOI:
10.13705/j.issn.1671-6825.2018.04.083
摘要:
目的:探讨FAM83A在肺腺癌组织中的表达及临床意义。方法:从癌症基因组图谱(TCGA)数据库中下载癌旁正常及肺腺癌组织中FAM83A mRNA表达的数据及其相关的临床资料。根据FAM83A mRNA表达量将肺腺癌患者分为FAM83A mRNA低表达组与高表达组,分析FAM83A mRNA的表达与患者临床病理特征的关系。结果:肺腺癌组FAM83A mRNA的表达高于癌旁正常对照组(P=0.001)。FAM83A mRNA的表达量与肺腺癌患者的临床分期、TNM分期中的T分期和N分期有关(P均<0.05)。FAM83A mRNA低表达组的中位生存时间为1 622 d,高于高表达组(1 357 d)(P=0.001)。结论:肺腺癌组织中FAM83A mRNA的表达升高; FAM83A mRNA高表达及临床分期较晚与肺腺癌预后不良有关。
Abstract:
Aim:To investigate the expression and clinical significance of FAM83A in lung adenocarcinoma tissue.Methods:The FAM83A mRNA expression data and corresponding clinical data of lung adenocarcinoma patients were downloaded from the Cancer Genome Atlas(TCGA)database, and were divided into para-cancer normal control group and lung adenocarcinoma group. According to the expression level of FAM83A mRNA, the patients with lung adenocarcinoma were divided into FAM83A low expression group and FAM83A high expression group. The relationships of FAM83A mRNA expression with the clinicopathological features and the prognosis of the patients were analyzed.Results:The expression of FAM83A mRNA in the lung adenocarcinoma group was higher than that in the para-cancer normal control group(P=0.001). Between FAM83A low expression group and FAM83A high expression group, there were significant differences in the clinical staging, T and N staging(all P<0.05).The median survival time of FAM83A low expression group and FAM83A high expression group was 1 622 days and 1 357 days,respectively, and the difference was significant(P=0.001).Conclusion:The expression of FAM83A mRNA is increased in lung adenocarcinoma tissue. The high expression of FAM83A mRNA is related to the late stage and prognosis of the patients.

参考文献/References:

[1] CHEN W,ZHENG R,ZUO T,et al.National cancer incidence and mortality in China, 2012[J].Chin J Cancer Res,2016,28(1):1
[2] PETRIELLA D,GALETTA D,RUBINI V,et al.Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancer[J].Mol Biotechnol,2013,54(3):913
[3] 丁粉干,刘标,张新华,等.不同肺腺癌分级评分系统在Ⅰ期肺腺癌预后评估中的意义[J].中华病理学杂志,2012,41(3):145
[4] JEMAL A,BRAY F,CENTER MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69
[5] 郭跃辉,高丰厚,时婧,等.表皮生长因子受体-细胞外信号调节激酶信号通路下调肺癌细胞中微小RNA145的表达[J].中华肿瘤杂志,2013,35(3):187
[6] LI Y,DONG X,YIN Y,et al.BJ-TSA-9,a novel human tumor-specific gene,has potential as a biomarker of lung cancer[J].Neoplasia,2005,7(12):1073
[7] 刘鹏辉,廖国清,李月敏,等.肺癌患者外周血BJ-TSA-9,LUNX和CK19 mRNA的检测及其临床意义[J].中国医科大学学报,2009,38(10):786
[8] 曲怡梅,廖国清,刘鹏辉,等.非小细胞肺癌患者外周血中BJ-TSA-9、CK19、Pre-proGRP mRNA的表达及联合检测的意义[J].中华医学杂志,2010,90(28):1958
[9] CHEN S,HUANG J,LIU Z,et al.FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer[J].Oncogenesis,2017,6(3):e300
[10]刘镭,黄亮,车清海,等.乳腺癌高表达基因FAM83A的生物信息学分析[J].重庆医学,2013,42(3):243
[11]CIPRIANO R,MISKIMEN KL,BRYSON BL,et al.Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer[J].Mol Cancer Res,2014,12(8):1156
[12]LIU L,MA CH,XU Q,et al.A rapid nested polymerase chain reaction method to detect circulating cancer cells in breast cancer patients using multiple marker genes[J].Oncol Lett,2014,7(6):2192
[13]LEE SY,MEIER R,FURUTA S,et al.FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice[J].J Clin Invest,2012,122(9):3211

相似文献/References:

[1]张立英),刘绍霞)#,赵国强),等.TNFα基因siRNA真核表达载体的构建及其对A549细胞TNFα和TGFβ1表达的影响*[J].郑州大学学报(医学版),2012,(05):629.
 ZHANG Liying),LIU Shaoxia),ZHAO Guoqiang),et al.Construction of eukaryotic expression vectors of siRNA against TNFα gene and their silencing effects on TNFα and TGFβ1 in A549 cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2012,(06):629.
[2]李杰),梁守沛),陆皓泉),等.肺腺癌组织中HSP70多肽复合物的分离及纯化*[J].郑州大学学报(医学版),2012,(06):753.
 LI Jie,LIANG Shoupei,LU Haoquan,et al.Separation and purification of heat shock protein 70 peptide complex from human lung adenocarcinoma tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2012,(06):753.
[3]杨继要,冯若,金辉,等.混合血清孵育的肺腺癌组织双向蛋白印迹图谱的建立*[J].郑州大学学报(医学版),2014,(01):45.
 YANG Jiyao,FENG Ruo,JIN Hui,et al.Establishment of 2dimensional Western blot maps of lung adenocarcinoma incubated with mixed sera[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(06):45.
[4]李 莎),吴 静),胡亚辉),等.Ⅳ期肺腺癌初诊时转移特征和生存分析*[J].郑州大学学报(医学版),2017,(04):443.[doi:10.13705/j.issn.1671-6825.2017.04.017]
 LI Sha),WU Jing),HU Yahui),et al.Features of initially presenting metastases and survival analysis in patients with stage Ⅳ lung adenocarcinoma[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(06):443.[doi:10.13705/j.issn.1671-6825.2017.04.017]
[5]吴 昊,林 庆,徐 全,等.ECT2-siRNA转染对肺腺癌A549细胞周期分布和凋亡的影响[J].郑州大学学报(医学版),2019,(03):406.[doi:10.13705/j.issn.1671-6825.2018.11.148]
 WU Hao,LIN Qing,XU Quan,et al.Effects of ECT2-siRNA transfection on cell cycle distribution and apoptosis of lung adenocarcinoma A549 cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(06):406.[doi:10.13705/j.issn.1671-6825.2018.11.148]

备注/Memo

备注/Memo:
【基金项目】 河南省基础与前沿技术研究计划项目(142300410376)
【作者简介】田蕊,通信作者,女,1963年12月生,本科,教授,主任医师,研究方向:肺癌的发病机制,E-mail:tianruiyfy@sina.com
更新日期/Last Update: 2018-11-20